To aid researchers in ADC development, BioIVT provides Ki67 staining procedures with pre-stained blocks and custom screens.

The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' case, however.

A new artificial intelligence model developed by researchers at The University of Texas at Austin paves the way for more ...

KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Renal Cell Carcinoma.

NIM Agent Blueprint based on cloud-native "microservices" aim to accelerate virtual screening of small molecules using generative models.

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...

Oberotatug ravtansine is under clinical development by Oxford BioTherapeutics and currently in Phase I for Ovarian Cancer.

Objective To explore associations between maternal body mass index (BMI) in early pregnancy and childhood infections. Design Birth cohort study linked to primary care records. Setting Bradford, UK.

Objective The relationship between low income and adverse perinatal outcomes, such as low birth weight and developmental ...